About one-half of early spontaneous preterm deliveries can be identified by a rapid matrix metalloproteinase-8 (MMP-8) bedside test at the time of mid-trimester genetic amniocentesis

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 29, Issue 15, 2016, Pages 2414-2422

  Kim, Sun Min ^a,b   Romero, Roberto ^c,d,e,f   Lee, JoonHo ^a   Chaemsaithong, Piya ^c,f   Lee, Min Woo ^a   Chaiyasit, Noppadol ^c,f   Lee, Hyo Jin ^a   Yoon, Bo Hyun ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amniotic fluid; intra amniotic inflammation infection; point of care (POC) test; preterm parturition

Indexed keywords

NEUTROPHIL COLLAGENASE; BIOLOGICAL MARKER; MMP8 PROTEIN, HUMAN;

AMNIOCENTESIS; AMNION FLUID; ARTICLE; CASE CONTROL STUDY; EARLY SPONTANEOUS PRETERM DELIVERY; GENETIC AMNIOCENTESIS; HIGH RISK PATIENT; HUMAN; INFECTION; INFLAMMATION; INFLAMMATORY CELL; NEWBORN; OBSTETRIC DELIVERY; POINT OF CARE TESTING; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ADULT; FEMALE; METABOLISM; POINT OF CARE SYSTEM; PREGNANCY; PREMATURE BIRTH; PROCEDURES; RISK ASSESSMENT;

ADULT; AMNIOCENTESIS; AMNIOTIC FLUID; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; MATRIX METALLOPROTEINASE 8; POINT-OF-CARE SYSTEMS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTERS; PREMATURE BIRTH; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84949207449     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2015.1094049     Document Type: Article

References (192)

1. Eisenberg B, Wapner RJ. Clinical proceduress in prenatal diagnosis. Best Pract Res Clin Obstet Gynaecol 2002; 16: 611-27
2. Simpson JL. Invasive procedures for prenatal diagnosis: any future left? Best Pract Res Clin Obstet Gynaecol 2012; 26: 625-38
3. Lo YM. Fetal nucleic acids in maternal blood: the promises. Clin Chem Lab Med 2012; 50: 995-8
4. Bianchi DW, Chudova D, Sehnert AJ, et al. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA 2015; 314: 162-9
5. Romero R, Mahoney MJ. Noninvasive prenatal testing and detection of maternal cancer. JAMA 2015; 314: 131-3
6. Canadian Agency for Drugs and Technologies in Health. Non-invasive prenatal testing: a review of the cost effectiveness and guidelines. Ottawa, ON; 2014 [cited 23 Oct 2015 ]. Available from: http://www.ncbi.nlm.nih-gov/books/NBK274056
7. Daley R, Hill M, Chitty LS. Non-invasive prenatal diagnosis: progress and potential. Arch Dis Child Fetal Neonatal Ed 2014; 99: F426-30
8. Platt LD, Janicki MB, Prosen T., et al. Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States. Am J Obstet Gynecol 2014; 211: 368 e1-7
9. Porreco RP, Garite TJ, Maurel K., et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol 2014; 211: 365 e1-12
10. Salomon LJ, Alfirevic Z, Audibert F., et al. ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice. Ultrasound Obstet Gynecol 2014; 44: 122-3
11. Allyse M, Minear MA, Berson E., et al. Non-invasive prenatal testing: a review of international implementation and challenges. Int J Womens Health 2015; 7: 113-26
12. Norton ME, Brar H, Weiss J., et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 207: 137 e1-8
13. Oepkes D, Tabor A, Yaron Y. Prenatal aneuploidy screening using cell free DNA. Am J Obstet Gynecol 2015; 21: 596-7
14. Bianchi DW. Pregnancy: prepare for unexpected prenatal test results. Nature 2015; 522: 29-30
15. Driscoll DA, Gross SJ. Screening for fetal aneuploidy and neural tube defects. Genet Med 2009; 11: 818-21
16. Devaney SA, Palomaki GE, Scott JA., et al. Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-Analysis. JAMA 2011; 306: 627-36
17. Norwitz ER, Levy B. Noninvasive prenatal testing: the future is now. Rev Obstet Gynecol 2013; 6: 48-62
18. Yu SC, Jiang P, Choy KW., et al. Noninvasive prenatal molecular karyotyping from maternal plasma. PLoS One 2013; 8: e60968
19. Wagner AJ, Mitchell ME, Tomita-Mitchell A. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening. Clin Perinatol 2014; 41: 957-66
20. Ferres MA, Hui L, Bianchi DW. Antenatal noninvasive DNA testing: clinical experience and impact. Am J Perinatol 2014; 31: 577-82
21. Robinson C, van den Boom D, Bombard AT. Noninvasive prenatal detection of aneuploidy. Clin Obstet Gynecol 2014; 57: 210-25
22. Society for Maternal-Fetal Medicine (SMFM) Publications Committee. #36: Prenatal aneuploidy screening using cell-free DNA. Am J Obstet Gynecol 2015; 212: 711-16
23. Thompson AE. JAMA PATIENT PAGE. noninvasive prenatal testing. JAMA 2015; 314: 198
24. Mennuti MT, Cherry AM, Morrissette JJ., et al. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? Am J Obstet Gynecol 2013; 209: 415-19
25. Williams J III, Rad S, Beauchamp S., et al. Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing. Am J Obstet Gynecol 2015; 213: 102 e1-6
26. Papp C, Beke A, Mezei G., et al. Chorionic villus sampling: a 15-year experience. Fetal Diagn Ther 2002; 17: 218-27
27. Papp C, Papp Z. Chorionic villus sampling and amniocentesis: what are the risks in current practice? Curr Opin Obstet Gynecol 2003; 15: 159-65
28. Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science 2014; 345: 760-5
29. Romero R, Mazor M, Wu YK., et al. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988; 12: 262-79
30. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988; 31: 553-84
31. Romero R, Sirtori M, Oyarzun E., et al. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989; 161: 817-24
32. Gibbs RS, Romero R, Hillier SL., et al A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992; 166: 1515-28
33. Fidel PL Jr, Romero R, Wolf N., et al. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 1994; 170: 1467-75
34. Gravett MG, Witkin SS, Haluska GJ., et al An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994; 171: 1660-7
35. Gomez R, Ghezzi F, Romero R., et al. Premature labor and intra-Amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol 1995; 22: 281-342
36. Hirsch E, Saotome I, Hirsh D A model of intrauterine infection and preterm delivery in mice. Am J Obstet Gynecol 1995; 172: 1598-603
37. Gomez R, Romero R, Edwin SS., et al. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am 1997; 11: 135-76
38. Yoon BH, Romero R, Moon JB., et al. Clinical significance of intra-Amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001; 185: 1130-6
39. Goncalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002; 8: 3-13
40. Shim SS, Romero R, Hong JS., et al. Clinical significance of intra-Amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 2004; 191: 1339-45
41. Hirsch E, Wang H. The molecular pathophysiology of bacterially induced preterm labor: insights from the murine model. J Soc Gynecol Investig 2005; 12: 145-55
42. Romero R, Espinoza J, Kusanovic JP., et al. The preterm parturition syndrome. BJOG 2006; 113: 17-42
43. Romero R, Espinoza J, Goncalves LF., et al. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007; 25: 21-39
44. Agrawal V, Hirsch E. Intrauterine infection and preterm labor. Semin Fetal Neonatal Med 2012; 17: 12-19
45. Combs CA, Gravett M, Garite T., et al. Abstract No. 73: intramniotic inflammation may be more important than the presence of microbes as a determinant of perinatal outcome in preterm labor. Am J Obstet Gynecol 2013; 208: S44
46. Romero R, Miranda J, Chaemsaithong P., et al. Sterile and microbial-Associated intra-Amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2015; 28: 1394-409
47. Romero R, Miranda J, Chaiworapongsa T., et al A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-Amniotic infection in preterm labor with intact membranes. Am J Reprod Immunol 2014; 71: 330-58
48. Romero R, Miranda J, Chaiworapongsa T., et al. Prevalence and clinical significance of sterile intra-Amniotic inflammation in patients with preterm labor and intact membranes. Am J Reprod Immunol 2014; 72: 458-74
49. Cobo T, Kacerovsky M, Jacobsson B. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol 2014; 211: 708
50. Combs CA, Gravett M, Garite TJ., et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol 2014; 210: 125 e1-15
51. Combs CA, Gravett M, Garite TJ. Reply: to PMID 24274987. Am J Obstet Gynecol 2014; 211: 708-9
52. Bujold E, Tétu A, Laforest G., et al. Abstract No. 22: midtrimester microbial invasion of the amniotic cavity and the risk of very preterm birth. Am J Obstet Gynecol 2014; 210: S15
53. Yoon BH, Romero R, Kim CJ., et al. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol 1995; 172: 960-70
54. Yoon BH, Romero R, Yang SH., et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996; 174: 1433-40
55. Yoon BH, Jun JK, Romero R., et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-Alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997; 177: 19-26
56. Gomez R, Romero R, Ghezzi F., et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179: 194-202
57. Ghezzi F, Gomez R, Romero R., et al. Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol 1998; 78: 5-10
58. Yoon BH, Romero R, Park JS., et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000; 183: 1124-9
59. Jobe AH, Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res 2001; 2: 27-32
60. Newnham JP, Moss TJ, Kramer BW., et al. The fetal maturational and inflammatory responses to different routes of endotoxin infusion in sheep. Am J Obstet Gynecol 2002; 186: 1062-8
61. Kallapur SG, Jobe AH. Contribution of inflammation to lung injury and development. Arch Dis Child Fetal Neonatal Ed 2006; 91: F132-5
62. Been JV, Rours IG, Kornelisse RF., et al. Histologic chorioamnionitis, fetal involvement, and antenatal steroids: effects on neonatal outcome in preterm infants. Am J Obstet Gynecol 2009; 201: 587 e1-8
63. Kramer BW, Kallapur S, Newnham J., et al. Prenatal inflammation and lung development. Semin Fetal Neonatal Med 2009; 14: 2-7
64. Jobe AH, Kallapur SG. Chorioamnionitis, surfactant, and lung disease in very low birth weight infants. J Pediatr 2010; 156: 3-4
65. Iliodromiti Z, Zygouris D, Sifakis S., et al. Acute lung injury in preterm fetuses and neonates: mechanisms and molecular pathways. J Matern Fetal Neonatal Med 2013; 26: 1696-704
66. Kim SM, Romero R, Park JW., et al. The relationship between the intensity of intra-Amniotic inflammation and the presence and severity of acute histologic chorioamnionitis in preterm gestation. J Matern Fetal Neonatal Med 2015; 28: 1500-9
67. Pugni L, Pietrasanta C, Acaia B., et al. Chorioamnionitis and neonatal outcome in preterm infants: a clinical overview. J Matern Fetal Neonatal Med 2015. [Epub ahead of print]. DOI: 10.3109/14767058.2015.1053862
68. Miyazaki K, Furuhashi M, Ishikawa K., et al. Impact of chorioamnionitis on short-And long-Term outcomes in very low birth weight preterm infants: the Neonatal Research Network Japan. J Matern Fetal Neonatal Med 2015. [Epub ahead of print]. DOI: 10.3109/14767058.2014.1000852
69. Bobitt JR, Hayslip CC, Damato JD. Amniotic fluid infection as determined by transabdominal amniocentesis in patients with intact membranes in premature labor. Am J Obstet Gynecol 1981; 140: 947-52
70. Cotton DB, Hill LM, Strassner HT., et al. Use of amniocentesis in preterm gestation with ruptured membranes. Obstet Gynecol 1984; 63: 38-43
71. Romero R, Emamian M, Quintero R., et al. The value and limitations of the Gram stain examination in the diagnosis of intraamniotic infection. Am J Obstet Gynecol 1988; 159: 114-19
72. Romero R, Quintero R, Oyarzun E., et al. Intraamniotic infection and the onset of labor in preterm premature rupture of the membranes. Am J Obstet Gynecol 1988; 159: 661-6
73. Asrat T, Nageotte MP, Garite TJ., et al. Gram stain results from amniocentesis in patients with preterm premature rupture of membranes-comparison of maternal and fetal characteristics. Am J Obstet Gynecol 1990; 163: 887-9
74. Romero R, Yoon BH, Mazor M., et al A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1993; 169: 839-51
75. Blanchard A, Hentschel J, Duffy L., et al. Detection of Ureaplasma urealyticum by polymerase chain reaction in the urogenital tract of adults, in amniotic fluid, and in the respiratory tract of newborns. Clin Infect Dis 1993; 17: S148-53
76. Gomez R, Romero R, Galasso M., et al. The value of amniotic fluid interleukin-6, white blood cell count, and gram stain in the diagnosis of microbial invasion of the amniotic cavity in patients at term. Am J Reprod Immunol 1994; 32: 200-10
77. Markenson GR, Martin RK, Tillotson-Criss M., et al. The use of the polymerase chain reaction to detect bacteria in amniotic fluid in pregnancies complicated by preterm labor. Am J Obstet Gynecol 1997; 177: 1471-7
78. Hitti J, Riley DE, Krohn MA., et al. Broad-spectrum bacterial rDNA polymerase chain reaction assay for detecting amniotic fluid infection among women in premature labor. Clin Infect Dis 1997; 24: 1228-32
79. Oyarzun E, Yamamoto M, Kato S., et al. Specific detection of 16 micro-organisms in amniotic fluid by polymerase chain reaction and its correlation with preterm delivery occurrence. Am J Obstet Gynecol 1998; 179: 1115-19
80. Blackwell SC, Berry SM. Role of amniocentesis for the diagnosis of subclinical intra-Amniotic infection in preterm premature rupture of the membranes. Curr Opin Obstet Gynecol 1999; 11: 541-7
81. Yoon BH, Romero R, Kim M., et al. Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol 2000; 183: 1130-7
82. Yoon BH, Romero R, Lim JH., et al. The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol 2003; 189: 919-24
83. Jacobsson B, Mattsby-Baltzer I, Andersch B., et al. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women with preterm prelabor rupture of membranes. Acta Obstet Gynecol Scand 2003; 82: 423-31
84. Jacobsson B, Mattsby-Baltzer I, Andersch B., et al. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women in preterm labor. Acta Obstet Gynecol Scand 2003; 82: 120-8
85. DiGiulio DB, Romero R, Amogan HP., et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One 2008; 3: e3056
86. DiGiulio DB, Romero R, Kusanovic JP., et al. Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol 2010; 64: 38-57
87. Oh KJ, Lee SE, Jung H., et al. Detection of ureaplasmas by the polymerase chain reaction in the amniotic fluid of patients with cervical insufficiency. J Perinat Med 2010; 38: 261-8
88. Holst RM, Hagberg H, Wennerholm UB., et al. Prediction of microbial invasion of the amniotic cavity in women with preterm labour: analysis of multiple proteins in amniotic and cervical fluids. BJOG 2011; 118: 240-9
89. Kacerovsky M, Pliskova L, Bolehovska R., et al. The microbial load with genital mycoplasmas correlates with the degree of histologic chorioamnionitis in preterm PROM. Am J Obstet Gynecol 2011; 205: 213 e1-7
90. Marconi C, de Andrade Ramos BR, Peracoli JC., et al. Amniotic fluid interleukin-1 beta and interleukin-6, but not interleukin-8 correlate with microbial invasion of the amniotic cavity in preterm labor. Am J Reprod Immunol 2011; 65: 549-56
91. Gervasi MT, Romero R, Bracalente G., et al. Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy. J Matern Fetal Neonatal Med 2012; 25: 2002-13
92. Allen-Daniels MJ, Serrano MG, Pflugner LP., et al. Identification of a gene in Mycoplasma hominis associated with preterm birth and microbial burden in intraamniotic infection. Am J Obstet Gynecol 2015; 212: 779 e1-e13
93. Romero R, Avila C, Santhanam U., et al. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest 1990; 85: 1392-400
94. Romero R, Sepulveda W, Kenney JS., et al. Interleukin 6 determination in the detection of microbial invasion of the amniotic cavity. Ciba Found Symp 1992; 167: 205-20. discussion 20-3
95. Romero R, Yoon BH, Kenney JS., et al. Amniotic fluid interleukin-6 determinations are of diagnostic and prognostic value in preterm labor. Am J Reprod Immunol 1993; 30: 167-83
96. Romero R, Yoon BH, Mazor M., et al. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1993; 169: 805-16
97. Hillier SL, Witkin SS, Krohn MA., et al. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993; 81: 941-8
98. Coultrip LL, Lien JM, Gomez R., et al. The value of amniotic fluid interleukin-6 determination in patients with preterm labor and intact membranes in the detection of microbial invasion of the amniotic cavity. Am J Obstet Gynecol 1994; 171: 901-11
99. Yoon BH, Romero R, Jun JK., et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-Alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997; 177: 825-30
100. Ghidini A, Jenkins CB, Spong CY., et al. Elevated amniotic fluid interleukin-6 levels during the early second trimester are associated with greater risk of subsequent preterm delivery. Am J Reprod Immunol 1997; 37: 227-31
101. Wenstrom KD, Andrews WW, Hauth JC., et al. Elevated second-Trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol 1998; 178: 546-50
102. Greci LS, Gilson GJ, Nevils B., et al. Is amniotic fluid analysis the key to preterm labor? A model using interleukin-6 for predicting rapid delivery. Am J Obstet Gynecol 1998; 179: 172-8
103. Wei SQ, Fraser W, Luo ZC. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol 2010; 116: 393-401
104. Gervasi MT, Romero R, Bracalente G., et al. Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-Amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm delivery. J Perinat Med 2012; 40: 329-43
105. Romero R, Kadar N, Miranda J., et al. The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-Amniotic inflammation is not superior to amniotic fluid interleukin-6. J Matern Fetal Neonatal Med 2014; 27: 757-69
106. Chaemsaithong P, Romero R, Korzeniewski SJ., et al A point of care test for the determination of amniotic fluid interleukin-6 and the chemokine CXCL-10/IP-10. J Matern Fetal Neonatal Med 2015; 28: 1510-9
107. Chaemsaithong P, Romero R, Korzeniewski SJ., et al A rapid interleukin-6 bedside test for the identification of intra-Amniotic inflammation in preterm labor with intact membranes. J Matern Fetal Neonatal Med 2015. [Epub ahead of print]. DOI: 10.3109/14767058.2015.1006620
108. Chaemsaithong P, Romero R, Korzeniewski SJ., et al A point of care test for interleukin-6 in amniotic fluid in preterm prelabor rupture of membranes: a step toward the early treatment of acute intra-Amniotic inflammation/infection. J Matern Fetal Neonatal Med 2015. [Epub ahead of print]. DOI: 10.3109/14767058.2015.1006621
109. Romero R, Brody DT, Oyarzun E., et al. Infection and labor. III. Interleukin-1: a signal for the onset of parturition. Am J Obstet Gynecol 1989; 160: 1117-23
110. Romero R, Mazor M, Brandt F., et al. Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. Am J Reprod Immunol 1992; 27: 117-23
111. Romero R, Sepulveda W, Mazor M., et al. The natural interleukin-1 receptor antagonist in term and preterm parturition. Am J Obstet Gynecol 1992; 167: 863-72
112. Romero R, Tartakovsky B. The natural interleukin-1 receptor antagonist prevents interleukin-1-induced preterm delivery in mice. Am J Obstet Gynecol 1992; 167: 1041-5
113. Mitchell MD, Edwin SS, Silver RM., et al. Potential agonist action of the interleukin-1 receptor antagonist protein: implications for treatment of women. J Clin Endocrinol Metab 1993; 76: 1386-8
114. Romero R, Mazor M, Sepulveda W., et al. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 1992; 166: 1576-87
115. Athayde N, Romero R, Maymon E., et al. Interleukin 16 in pregnancy, parturition, rupture of fetal membranes, and microbial invasion of the amniotic cavity. Am J Obstet Gynecol 2000; 182: 135-41
116. Pacora P, Romero R, Maymon E., et al. Participation of the novel cytokine interleukin 18 in the host response to intra-Amniotic infection. Am J Obstet Gynecol 2000; 183: 1138-43
117. Greig PC, Herbert WN, Robinette BL., et al. Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection. Am J Obstet Gynecol 1995; 173: 1223-7
118. Gotsch F, Romero R, Kusanovic JP., et al. The anti-inflammatory limb of the immune response in preterm labor, intra-Amniotic infection/inflammation, and spontaneous parturition at term: a role for interleukin-10. J Matern Fetal Neonatal Med 2008; 21: 529-47
119. Romero R, Ceska M, Avila C., et al. Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol 1991; 165: 813-20
120. Cherouny PH, Pankuch GA, Romero R., et al. Neutrophil attractant/activating peptide-1/interleukin-8: association with histologic chorioamnionitis, preterm delivery, and bioactive amniotic fluid leukoattractants. Am J Obstet Gynecol 1993; 169: 1299-303
121. Maymon E, Romero R, Pacora P., et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol 2000; 183: 94-9
122. Yoon BH, Oh SY, Romero R., et al An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-Trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2001; 185: 1162-7
123. Maymon E, Romero R, Chaiworapongsa T., et al. Amniotic fluid matrix metalloproteinase-8 in preterm labor with intact membranes. Am J Obstet Gynecol 2001; 185: 1149-55
124. Maymon E, Romero R, Chaiworapongsa T., et al. Value of amniotic fluid neutrophil collagenase concentrations in preterm premature rupture of membranes. Am J Obstet Gynecol 2001; 185: 1143-8
125. Moon JB, Kim JC, Yoon BH., et al. Amniotic fluid matrix metalloproteinase-8 and the development of cerebral palsy. J Perinat Med 2002; 30: 301-6
126. Biggio JR Jr, Ramsey PS, Cliver SP., et al. Midtrimester amniotic fluid matrix metalloproteinase-8 (MMP-8) levels above the 90th percentile are a marker for subsequent preterm premature rupture of membranes. Am J Obstet Gynecol 2005; 192: 109-13
127. Nien JK, Yoon BH, Espinoza J., et al A rapid MMP-8 bedside test for the detection of intra-Amniotic inflammation identifies patients at risk for imminent preterm delivery. Am J Obstet Gynecol 2006; 195: 1025-30
128. Kim KW, Romero R, Park HS., et al A rapid matrix metalloproteinase-8 bedside test for the detection of intraamniotic inflammation in women with preterm premature rupture of membranes. Am J Obstet Gynecol 2007; 197: 292 e1-5
129. Park CW, Lee SM, Park JS., et al. The antenatal identification of funisitis with a rapid MMP-8 bedside test. J Perinat Med 2008; 36: 497-502
130. Lee SJ, Won HS, Kim MN., et al. Diagnostic value of the matrix metalloproteinase-8 rapid test for detecting microbial invasion of the amniotic cavity. Eur J Clin Microbiol Infect Dis 2008; 27: 1257-60
131. Conde-Agudelo A, Papageorghiou AT, Kennedy SH., et al. Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-Analysis. BJOG 2011; 118: 1042-54
132. Park CW, Yoon BH, Kim SM., et al. The frequency and clinical significance of intra-Amniotic inflammation defined as an elevated amniotic fluid matrix metalloproteinase-8 in patients with preterm labor and low amniotic fluid white blood cell counts. Obstet Gynecol Sci 2013; 56: 167-75
133. Chaemsaithong P, Romero R, Docheva N., et al A rapid point-of-care test (MMP-8) for the identification of intra-Amniotic inflammation and impending preterm delivery. Abstract presented at the 12th World Congress of Perinatal Medicine, 3-6 November 2015, Madrid, Spain
134. Chaemsaithong P, Romero R, Chaiyasit N., et al. Rapid MMP-8 as a point-of-care test in the identification of intra-Amniotic inflammation in patients with preterm PROM. Abstract presented at the 12th World Congress of Perinatal Medicine, 3-6 November 2015, Madrid, Spain
135. Park HS, Kim SA. Abstract No. 322: the value of the genedia MMP-8 rapid test for diagnosing intraamniotic infection/inflammation and predicting adverse pregnancy outcomes in women with preterm premature rupture of membranes. Am J Obstet Gynecol 2015; 212: S174
136. Kim SM, Lee JH, Park CW., et al. Abstract no. 556: one third of early spontaneous preterm delivery can be identified by a rapid matrix metalloproteinase-8 (MMP-8) bedside test at the time of mid-Trimester genetic amniocentesis. Am J Obstet Gynecol 2015; 212: S277
137. Maymon E, Romero R, Pacora P., et al. Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1) in preterm premature rupture of membranes. Am J Obstet Gynecol 2000; 183: 914-20
138. Maymon E, Romero R, Pacora P., et al A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection. J Perinat Med 2001; 29: 308-16
139. Park KH, Chaiworapongsa T, Kim YM., et al. Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity. J Perinat Med 2003; 31: 12-22
140. Maymon E, Romero R, Pacora P., et al. Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection. Am J Obstet Gynecol 2000; 182: 1545-53
141. Athayde N, Romero R, Gomez R., et al. Matrix metalloproteinases-9 in preterm and term human parturition. J Matern Fetal Med 1999; 8: 213-19
142. Locksmith GJ, Clark P, Duff P., et al. Amniotic fluid matrix metalloproteinase-9 levels in women with preterm labor and suspected intra-Amniotic infection. Obstet Gynecol 1999; 94: 1-6
143. Maymon E, Romero R, Pacora P., et al. Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-Amniotic infection. Am J Obstet Gynecol 2000; 183: 887-94
144. Locksmith GJ, Clark P, Duff P., et al. Amniotic fluid concentrations of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during pregnancy and labor. Am J Obstet Gynecol 2001; 184: 159-64
145. Harirah H, Donia SE, Hsu CD. Amniotic fluid matrix metalloproteinase-9 and interleukin-6 in predicting intra-Amniotic infection. Obstet Gynecol 2002; 99: 80-4
146. Esplin MS, Romero R, Chaiworapongsa T., et al. Amniotic fluid levels of immunoreactive monocyte chemotactic protein-1 increase during term parturition. J Matern Fetal Neonatal Med 2003; 14: 51-6
147. Esplin MS, Romero R, Chaiworapongsa T., et al. Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-Amniotic infection. J Matern Fetal Neonatal Med 2005; 17: 365-73
148. Mittal P, Romero R, Kusanovic JP., et al. CXCL6 (granulocyte chemotactic protein-2): a novel chemokine involved in the innate immune response of the amniotic cavity. Am J Reprod Immunol 2008; 60: 246-57
149. Nhan-Chang CL, Romero R, Kusanovic JP., et al A role for CXCL13 (BCA-1) in pregnancy and intra-Amniotic infection/inflammation. J Matern Fetal Neonatal Med 2008; 21: 763-75
150. Keelan JA, Wang K, Chaiworapongsa T., et al. Macrophage inhibitory cytokine 1 in fetal membranes and amniotic fluid from pregnancies with and without preterm labour and premature rupture of membranes. Mol Hum Reprod 2003; 9: 535-40
151. Keelan JA, Yang J, Romero RJ., et al. Epithelial cell-derived neutrophil-Activating peptide-78 is present in fetal membranes and amniotic fluid at increased concentrations with intra-Amniotic infection and preterm delivery. Biol Reprod 2004; 70: 253-9
152. Athayde N, Romero R, Maymon E., et al A role for the novel cytokine RANTES in pregnancy and parturition. Am J Obstet Gynecol 1999; 181: 989-94
153. Mitchell MD, Chang MC, Chaiworapongsa T., et al. Identification of 9alpha,11beta-prostaglandin F2 in human amniotic fluid and characterization of its production by human gestational tissues. J Clin Endocrinol Metab 2005; 90: 4244-8
154. Pacora P, Romero R, Chaiworapongsa T., et al. Amniotic fluid angiopoietin-2 in term and preterm parturition, and intra-Amniotic infection/inflammation. J Perinat Med 2009; 37: 503-11
155. Kusanovic JP, Romero R, Chaiworapongsa T., et al. Amniotic fluid sTREM-1 in normal pregnancy, spontaneous parturition at term and preterm, and intra-Amniotic infection/inflammation. J Matern Fetal Neonatal Med 2010; 23: 34-47
156. Romero R, Espinoza J, Hassan S., et al. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation. J Perinat Med 2008; 36: 388-98
157. Romero R, Chaiworapongsa T, Alpay Savasan Z., et al. Damage-Associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1. J Matern Fetal Neonatal Med 2011; 24: 1444-55
158. Romero R, Chaiworapongsa T, Savasan ZA., et al. Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE. J Matern Fetal Neonatal Med 2012; 25: 558-67
159. Romero R, Chaemsaithong P, Korzeniewski SJ., et al. Clinical chorioamnionitis at term II: the intra-Amniotic inflammatory response. J Perinat Med 2015; Epub 2015/05/06
160. Romero R, Grivel JC, Tarca AL., et al. Evidence of perturbations of the cytokine network in preterm labor. Am J Obstet Gynecol 2015; Epub 2015/08/02
161. Park CW, Yoon BH, Jun JK., et al. Abstract no. 469: approximately one-fifth of patients with preterm labor and intact membranes and low amniotic fluid white blood cell counts have evidence of intra-Amniotic inflammation and are at risk for impending preterm delivery when MMP-8 is used. Am J Obstet Gynecol 2012; 206: S214
162. Sampson JE, Theve RP, Blatman RN., et al. Fetal origin of amniotic fluid polymorphonuclear leukocytes. Am J Obstet Gynecol 1997; 176: 77-81
163. Kim M, Kim G, Romero R., et al. Biovar diversity of ureaplasma urealyticum in amniotic fluid: distribution, intrauterine inflammatory response and pregnancy outcomes. J Perinat Med 2003; 31: 146-52
164. Yi J, Yoon BH, Kim EC. Detection and biovar discrimination of Ureaplasma urealyticum by real-Time PCR. Mol Cell Probes 2005; 19: 255-60
165. Oh KJ, Lee KA, Sohn YK., et al. Intraamniotic infection with genital mycoplasmas exhibits a more intense inflammatory response than intraamniotic infection with other microorganisms in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 2010; 203: 211 e1-8
166. Rodriguez N, Fernandez C, Zamora Y., et al. Detection of Ureaplasma urealyticum and Ureaplasma parvum in amniotic fluid: association with pregnancy outcomes. J Matern Fetal Neonatal Med 2011; 24: 47-50
167. Romero R, Emamian M, Wan M., et al. The value of the leukocyte esterase test in diagnosing intra-Amniotic infection. Am J Perinatol 1988; 5: 64-9
168. Romero R, Jimenez C, Lohda AK., et al. Amniotic fluid glucose concentration: a rapid and simple method for the detection of intraamniotic infection in preterm labor. Am J Obstet Gynecol 1990; 163: 968-74
169. Gauthier DW, Meyer WJ, Bieniarz A. Correlation of amniotic fluid glucose concentration and intraamniotic infection in patients with preterm labor or premature rupture of membranes. Am J Obstet Gynecol 1991; 165: 1105-10
170. Gauthier DW, Meyer WJ. Comparison of gram stain, leukocyte esterase activity, and amniotic fluid glucose concentration in predicting amniotic fluid culture results in preterm premature rupture of membranes. Am J Obstet Gynecol 1992; 167: 1092-5
171. Greig PC, Ernest JM, Teot L. Low amniotic fluid glucose levels are a specific but not a sensitive marker for subclinical intrauterine infections in patients in preterm labor with intact membranes. Am J Obstet Gynecol 1994; 171: 365-70. discussion 70-1
172. Hazan Y, Mazor M, Horowitz S., et al. The diagnostic value of amniotic fluid Gram stain examination and limulus amebocyte lysate assay in patients with preterm birth. Acta Obstet Gynecol Scand 1995; 74: 275-80
173. Yoon BH, Yang SH, Jun JK., et al. Maternal blood C-reactive protein, white blood cell count, and temperature in preterm labor: a comparison with amniotic fluid white blood cell count. Obstet Gynecol 1996; 87: 231-7
174. Carroll SG, Philpott-Howard J, Nicolaides KH. Amniotic fluid gram stain and leukocyte count in the prediction of intrauterine infection in preterm prelabour amniorrhexis. Fetal Diagn Ther 1996; 11: 1-5
175. Gonzalez-Bosquet E, Cerqueira MJ, Dominguez C., et al. Amniotic fluid glucose and cytokines values in the early diagnosis of amniotic infection in patients with preterm labor and intact membranes. J Matern Fetal Med 1999; 8: 155-8
176. Romero R, Miranda J, Chaiworapongsa T., et al. Sterile intra-Amniotic inflammation in asymptomatic patients with a sonographic short cervix: prevalence and clinical significance. J Matern Fetal Neonatal Med 2014. [Epub ahead of print]. DOI: 10.3109/14767058.2014.954243
177. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296: 301-5
178. Harris HE, Raucci A. Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep 2006; 7: 774-8
179. Oppenheim JJ, Tewary P, de la Rosa G., et al. Alarmins initiate host defense. Adv Exp Med Biol 2007; 601: 185-94
180. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81: 1-5
181. Gotsch F, Romero R, Chaiworapongsa T., et al. Evidence of the involvement of caspase-1 under physiologic and pathologic cellular stress during human pregnancy: a link between the inflammasome and parturition. J Matern Fetal Neonatal Med 2008; 21: 605-16
182. Bianchi ME, Manfredi AA. Immunology. Dangers in and out. Science 2009; 323: 1683-4
183. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010; 10: 826-37
184. Dubicke A, Andersson P, Fransson E., et al. High-mobility group box protein 1 and its signalling receptors in human preterm and term cervix. J Reprod Immunol 2010; 84: 86-94
185. Nunez G. Intracellular sensors of microbes and danger. Immunol Rev 2011; 243: 5-8
186. Ahmed AI, Chaemsaithong P, Chaiwaropongsa TZ., et al. 599: A receptor for danger signals, advanced glycation end products (RAGE) in fetal systemic inflammation and clinical chorioamnionitis. Am J Obstet Gynecol 2015; 212: S298
187. Keelan JA, Khan S, Yosaatmadja F., et al. Prevention of inflammatory activation of human gestational membranes in an ex vivo model using a pharmacological NF-kappaB inhibitor. J Immunol 2009; 183: 5270-8
188. Pirianov G, Waddington SN, Lindstrom TM., et al. The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J(2) delays lipopolysaccharide-induced preterm delivery and reduces mortality in the newborn mouse. Endocrinology 2009; 150: 699-706
189. Nath CA, Ananth CV, Smulian JC., et al. Can sulfasalazine prevent infection-mediated pre-Term birth in a murine model? Am J Reprod Immunol 2010; 63: 144-9
190. Stinson LF, Ireland DJ, Kemp MW., et al. Effects of cytokine-suppressive anti-inflammatory drugs on inflammatory activation in ex vivo human and ovine fetal membranes. Reproduction 2014; 147: 313-20
191. Ireland DJ, Kemp MW, Miura Y., et al. Intra-Amniotic pharmacological blockade of inflammatory signalling pathways in an ovine chorioamnionitis model. Mol Hum Reprod 2015; 21: 479-89
192. Ng PY, Ireland DJ, Keelan JA. Drugs to block cytokine signaling for the prevention and treatment of inflammation-induced preterm birth. Front Immunol 2015; 6: 166